COPD assessment: I, II, III, IV and/or A, B, C, D

European Respiratory Journal

Volumn 43, Issue 4, 2014, Pages 949-950

  Vogelmeier, Claus ^a,b   Vestbo, Jørgen ^c,d  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b German Center for Lung Research (DZL)   (Germany)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; COMORBIDITY; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EDITORIAL; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MEDICAL LITERATURE; PREDICTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; FEMALE; GENERAL PRACTICE; MALE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONOLOGY; STANDARDS;

FEMALE; GENERAL PRACTICE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE;

EID: 84897375295     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00019714     Document Type: Editorial

References (10)

1. Pauwels RA, Buist AS, Ma P, et al GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001; 46: 798-825.
2. Agusti A, Calverley PM, Celli B, et al Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
3. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
4. Agusti A, Edwards LD, Celli B, et al ECLIPSE Investigators. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 2013; 42: 636-646.
5. Han MK, Muellerova H, Curran-Everett D, et al GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013; 1: 43-50.
6. Lange P, Marott JL, Vestbo J, et al Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981.
7. Soriano JB, Alfageme I, Almagro P., et al Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest 2013; 143: 694-702.
8. Agusti A, Hurd S, Jones P., et al FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J 2013; 42: 1391-1401.
9. Haughney J, Gruffydd-Jones K, Roberts J., et al The distribution of COPD in UK general practice using the new GOLD classification. Eur Respir J 2014; 43: 993-1002.
10. Jones PW, Adamek L, Nadeau G., et al Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J 2013; 42: 647-654.